Examining Effects of Ocrevus on Cognitive Fatigue Using fMRI
Palo Alto (17 mi)Overseen byJohn DeLuca, PhD
Age: 18 - 65
Sex: Any
Travel: May be covered
Time Reimbursement: Varies
Trial Phase: N/A
Recruiting
Sponsor: Kessler Foundation
No Placebo Group
Breakthrough Therapy
Trial Summary
What is the purpose of this trial?The purpose of this research study is to investigate the effectiveness of MS Disease modifying medications on cognitive fatigue in persons with relapsing remitting multiple sclerosis (RRMS). Cognitive fatigue is the kind of fatigue that occurs after intense mental concentration as after a session of problem solving.
Eligibility Criteria
Treatment Details
3Treatment groups
Experimental Treatment
Group I: Multiple Sclerosis group 2Experimental Treatment0 Interventions
Individuals with Multiple Sclerosis who are going to be starting Copaxone as determined by Neurologist as part of clinical care.
Group II: Multiple Sclerosis group 1Experimental Treatment1 Intervention
Individuals with Multiple Sclerosis who are going to be starting Ocrevus as determined by Neurologist as part of clinical care.
Group III: Healthy ControlsExperimental Treatment0 Interventions
Healthy individuals who are age, gender and education matched to the other groups.
Find a clinic near you
Research locations nearbySelect from list below to view details:
Kessler FoundationWest Orange, NJ
Loading ...
Who is running the clinical trial?
Kessler FoundationLead Sponsor
Hackensack Meridian HealthCollaborator